Does damage cause inflammation? Revisiting the link between joint damage and inflammation

Annals of the Rheumatic Diseases

Volumn 68, Issue 2, 2009, Pages 159-162

  Smolen, J S ^a,b   Aletaha, D ^a   Steiner, G ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Hietzing Hospital   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNITY; BONE INJURY; DISEASE ACTIVITY; IMMUNE RESPONSE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; TISSUE INJURY;

ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; HUMANS; IMMUNE COMPLEX DISEASES; INFLAMMATION;

EID: 58849122797     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.099382     Document Type: Review

References (50)

1. Drossaers-Bakker KW, de Buck M, van Zeben D, Zwinderman AH, Breedveld FC, Hazes JM. Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum 1999;42:1854-60.
2. Aletaha D, Smolen J, Ward MM. Measuring function in rheumatoid arthritis: identifying reversible and irreversible components. Arthritis Rheum 2006;54:2784-92.
3. Welsing PM, Landewe RB, van Riel PL, Boers M, van Gestel AM, van der LS, et al. The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. Arthritis Rheum 2004;50:2082-93.
4. van Leeuwen MA, Van der Heijde DM, van Rijswijk MH, Houtman PM, van Riel PL, van de Putte LB, et al. Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. J Rheumatol 1994;21:425-9.
5. van Leeuwen MA, van Rijswijk MH, Sluiter WJ, van Riel PL, Kuper IH, van de Putte LB, et al. Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system. J Rheumatol 1997;24:20-7.
6. Scott DL. Prognostic factors in early rheumatoid arthritis. Rheumatology (Oxford) 2000;39(Suppl 1):24-9.
7. Bukhari M, Lunt M, Harrison BJ, Scott DG, Symmons DP, Silman AJ. Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum 2002;46:906-12.
8. Nell V, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M, et al. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 2005;64:1731-6.
9. Kroot EJ, de Jong BA, van Leeuwen MA, Swinkels H, van den Hoogen FH, van't Hof M, et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000;43:1831-5.
10. Smolen JS, van der Heijde DMFM, St Clair EW, Emery P, Bathon JM, Keystone E, et al. Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate without or with concomitant infliximab. Results from the ASPIRE trial. Arthritis Rheum 2006;54:702-10.
11. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;23:361.
12. Smolen JS, Aletaha D, Koeller M, Weisman M, Emery P. New therapies for the treatment of rheumatoid arthritis. Lancet 2007;370:1861- 74.
13. Feldmann M, Brennan FM, Foxwell BM, Maini FIN. The role of TNF α and IL-1 in rheumatoid arthritis. Curr Dir Autoimmun 2001;3:188-99.
14. Welsing PM, van Gestel AM, Swinkels HL, Kiemeney LA, van Riel PL. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum 2001;44:2009-17.
15. Veale DJ, Ritchlin C, Fitzgerald O. Immunopathology of psoriasis and psoriatic arthritis. Ann Rheum Dis 2005;64(Suppl 2):ii26-9.
16. Smeets TJ, Dolhain RJ, Breedveld FC, Tak PP. Analysis of the cellular infiltrates and expression of cytokines in synovial tissue from patients with rheumatoid arthritis and reactive arthritis. J Pathol 1998;186:75-81.
17. Partsch G, Steiner G, Leeb BF, Dunky A, Broil H, Smolen JS. Highly increased levels of tumor necrosis factor-α and other proinflammatory cytokines in psoriatic arthritis synovia! fluid. J Rheumatol 1997;24:518-23.
18. Nielen MM, van der Horst AR, van Schaardenburg D, van der Horst-Bruinsma IE, van de Stadt RJ, Aarden L, et al. Antibodies to citrullinated human fibrinogen (acf) have diagnostic and prognostic value in early arthritis. Ann Rheum Dis 2005;64:1199-204.
19. Aho K, von Essen R, Kurki P, Palusuo T, Heliovaara M. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. J Rheumatol 1993;20:1278-81.
20. Jasin HE. Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1985;28:241-8.
21. Zvaifler NJ. Breakdown products of C 3 in human synovial fluids. J Clin Invest 1969;48:1532-42.
22. Kleinau S, Martinsson P, Heyman B. Induction and suppression of collagen-induced arthritis is dependent on distinct fey receptors. J Exp Med 2000;191:1611-16.
23. Debets JM, Van der Linden CJ, Dieteren IE, LJ, Buurman WA. Fc-receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes. J Immunol 1988;141:1197-201
24. Scott DG, Bacon PA, Allen C, Elson CJ, Wallington T. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy. Clin Exp Immunol 1981;43:54-63.
25. Menzel J, Steffen C, Kolarz G, Eberal G, Frank O, Thumb N. Demonstration of antibodies to collagen and of collagen-anticollagen immune complexes in rheumatoid arthritis synovial fluids. Ann Rheum Dis 1975;35:446-50.
26. Smolen JS, Hassfeld W, Steiner G. Rheumatoid arthritis. N Engl J Med 1990;323:994-5.
27. Zhao X, Okeke NL, Sharpe O, Batliwalla FM, Lee AT, Ho PP, et al. Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Res Ther 2008;10:R94.
28. Mattey DL, Dawes PT, Clarke S, Fisher J, Brownfield A, Thomson W, et al. Relationship among the HLA-DRB1 shared epitope, smoking and rheumatoid factor production in rheumatoid arthritis. Arthritis Rheum 2002;47:403-7.
29. Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 2003;171:538- 41.
30. Steffen C. Consideration of pathogenesis of rheumatoid arthritis as collagen autoimmunity. Z Immunitatsforsch Allerg Klin Immunol 1970;139:219-27.
31. Trentham DE, Dynesius RA. Rocklin RE. David JR. Cellular sensitivity to collagen in rheumatoid arthritis. N Engl J Med 1978;299:327-32.
32. Menzel J, Steffen C. Kolarz G, Kojer M, Smolen J. Demonstration of anticollagen antibodies in rheumatoid arthritis synovial fluids by 14C-radioimmunoassay. Arthritis Rheum 1978;21:243-8
33. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 1977;146:857-68.
34. Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006;116:961-73.
35. Hanauske-Abel HM, Pontz BF, Schorlemmer HU. Cartilage specific collagen activates macrophages and the alternative pathway of complement: evidence for an immunopathogenic concept of rheumatoid arthritis. Ann Rheum Dis 1982;41:168-76.
36. Giant TT, Cs-Szabo G, Nagase H, Jacobs JJ, Mikecz K. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage. Arthritis Rheum 1998;41:1007-18.
37. Rose NR. Mechanisms of autoimmunity. Semin Liver Dis 2002;22:387-94.
38. van Meurs JB, van Lent PL, Holthuysen AE, Singer II. Bayne EK, van Den Berg WB. Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis. Arthritis Rheum 1999;42:1128-39
39. Landewe RB, Geusens P, van der Heijde D, Boers M, van der Linden S, Garnero P. Arthritis instantaneously causes collagen type-l and type-ll degradation in patients with early rheumatoid arthritis. A longitudinal analysis. Ann Rheum Dis 2006;65:40-4
40. Smolen JS, Aletaha D, Grisar J, Redlich K, Steiner G, Wagner O. The need for prognosticators in rheumatoid arthritis. Biological and clinical markers - where are we now? Arthritis Res Ther 2008;10:208
41. Burkhardt HJ, Sehnert B, Bochermann R, Engstrom A, Kalden JR, Holmdahl R. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis. Europ J Immunol 2005;35:1643-52.
42. Haver S, Tohidast-Akrad M, Haralambous S, Jahn-Schmid B, Sknner K. Trembleau S et al. Aberrant expression of the autoantigen heterogeneous nuclear ribonucleoprotein-A2 (RA33) and spontaneous formation of rheumatoid arthritis- associated anti-RA33 autoantibodies in TNF-α transgenic mice. J Immunol 2005;175:8327-36.
43. Kato T, Xiang Y, Nakamura H, Nishioka K. Neoantigens in osteoarthritic cartilage Curr Opin Rheumatol 2004;16:604-8.
44. Zvaifler NJ. New perspectives on the pathogenesis of rheumatoid arthritis Am J Med 1988;85:12-17.
45. Paus AC, Mellbye OJ, Forre O Immunohistopathologic findings in synovial biopsies before and after synovectomy in patients with chronic inflammatory joint diseases and their relation to clinical evaluation. A prospective study of biopsies taken from areas selected by arthroscopy. Scand J Rheumatol 1990;19:269-79
46. Roch-Bras F, Daures JP, Legouffe MC, Sany J, Combe B Treatment of chronic knee synovitis with arthroscopic synovectomy: longterm results J Rheumatol 2002;29:1171-5.
47. Konttinen YT, Li TF, Lassus J, Wans V, Santavirta S, Virtanen I Removal of hyaline articular cartilage reduces lymphocyte infiltration and activation in rheumatoid synovial membrane. J Rheumatol 2001;28:2184-9.
48. Fiocco U, Cozzi L, Rigon C, Chieco-Bianchi F. Baldovin M, Cassisi GA, et al Arthroscopic synovectomy in rheumatoid and psoriatic knee joint synovitis long-term outcome. Br J Rheumatol 1996;35:463-70.
49. van Lent PL, Grevers L, Lubberts E. de Vnes Tj, Nabbe KC. Verbeek S. et al Foy receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation. Arthritis Rheum 2006;54:3868-77
50. Smolen JS, van der Heijde DM, Aletaha D, Xu S, Han J, Baker D, et al Progression of radiographic joint damage in rheumatoid arthritis: independence of erosins and joint space narrowing. Ann Rheum Dis. Published Online First 28 October 2008